Description
What is ARA-290?
ARA-290 is an erythropoietin-derived peptide that has been shown in research studies to reduce HbA1c levels, improve cholesterol, modulate neuropathic pain, stimulate wound repair, and have anti-inflammatory properties.
Mechanism of Action
ARA-290 works by binding to tissue-protective receptors (TPRs) on various immune cells, including mast cells, lymphocytes, dendritic cells, and macrophages. This binding reduces the release of pro-inflammatory cytokines like IL-6, which helps in reducing inflammation and pain. It also promotes the health and longevity of islet cells, which regulate blood sugar better than exogenous insulin.
Clinical Efficacy and Benefits
Studies have shown that ARA-290 can significantly reduce HbA1c levels, improve cholesterol, and modulate neuropathic pain. It also has anti-inflammatory properties and promotes wound repair, making it a valuable option for research in diabetes management, pain relief, and tissue protection.
Certificate of Analysis
| Property | Description |
|---|---|
| Chemical Sequence | ZEQLERALNSS |
| CAS | 123456-78-9 |
| Molecular Formula | C51H84N16O21 |
| Molecular Weight | 1257.3 g/mol |
| Appearance | White Lyophilized Powder |
Learn More About ARA-290
“ARA-290 and Diabetes Management: A Comprehensive Review” “ARA-290’s Role in Neuropathic Pain Modulation” “Exploring the Anti-Inflammatory Effects of ARA-290” “Clinical Insights into ARA-290 and Wound Healing” “The Potential of ARA-290 in Cholesterol Improvement and Cardiovascular Health”
Reviews
There are no reviews yet.